Clinical trial results for lecanemab are a significant step for Alzheimer's, but not a historic breakthrough

by University of New South WalesAmyloid plaques and neurofibrillary tangles occur in the brains of patients with Alzheimer's disease. Credit: Ian JosonPartner companies Eisai and Biogen recen

Updated on: March 30,2024

Clinical trial results for lecanemab are a significant step for Alzheimer's, but not a historic breakthrough

by University of New South WalesAmyloid plaques and neurofibrillary tangles occur in the brains of patients with Alzheimer's disease. Credit: Ian JosonPartner companies Eisai and Biogen recen

Updated on:March 30,2024

Extra-large synapses could be a cause of schizophrenia

by RIKENExtra-strong synapses could play an important role in psychiatric disorders such as schizophrenia, a study by RIKEN researchers finds. Credit: Equinox Graphics/Science Photo LibrarySchizo

Updated on: February 03,2024

Extra-large synapses could be a cause of schizophrenia

by RIKENExtra-strong synapses could play an important role in psychiatric disorders such as schizophrenia, a study by RIKEN researchers finds. Credit: Equinox Graphics/Science Photo LibrarySchizo

Updated on:February 03,2024

Cognitive impairment afflicts majority of stroke patients

by Wenche Margrethe Kulmo,Norwegian University of Science and TechnologyCredit: Marcus Aurelius from PexelsParalysis and difficulty speaking are well-known problems following a stroke. Establish

Updated on: February 18,2024

Cognitive impairment afflicts majority of stroke patients

by Wenche Margrethe Kulmo,Norwegian University of Science and TechnologyCredit: Marcus Aurelius from PexelsParalysis and difficulty speaking are well-known problems following a stroke. Establish

Updated on:February 18,2024

Three-minute test detects common form of dementia that's hard to diagnose

by Florida Atlantic UniversityJames E. Galvin, M.D., M.P.H., one of the most prominent neuroscientists in the country, and a professor in FAU's Charles E. Schmidt College of Medicine and Chri

Updated on: February 26,2024

Three-minute test detects common form of dementia that's hard to diagnose

by Florida Atlantic UniversityJames E. Galvin, M.D., M.P.H., one of the most prominent neuroscientists in the country, and a professor in FAU's Charles E. Schmidt College of Medicine and Chri

Updated on:February 26,2024

Unreliable neurons improve brain functionalities

by Bar-Ilan UniversityCredit: Pixabay/CC0 Public DomainThe brain is composed of millions of billions of neurons that communicate with one another. Each neuron collects its many inputs and transmi

Updated on: February 05,2024

Unreliable neurons improve brain functionalities

by Bar-Ilan UniversityCredit: Pixabay/CC0 Public DomainThe brain is composed of millions of billions of neurons that communicate with one another. Each neuron collects its many inputs and transmi

Updated on:February 05,2024

Imaging of a living brain can help clearly differentiate between two types of dementia

by Champalimaud Centre for the UnknownSPECT images, superimposed on a magnetic resonance atlas, of an axial slice (top row) and a sagittal slice (bottom row) of the human brain, with a quantitative ar

Updated on: June 11,2024

Imaging of a living brain can help clearly differentiate between two types of dementia

by Champalimaud Centre for the UnknownSPECT images, superimposed on a magnetic resonance atlas, of an axial slice (top row) and a sagittal slice (bottom row) of the human brain, with a quantitative ar

Updated on:June 11,2024

First 'gene silencing' drug for Alzheimer's disease shows promise

by University College LondonEffect of MAPTRxon CSF concentrations of p-tau protein and tau/Aβ42. a, The mean percentage change from baseline in p-tau over time according to dose group. b, T

Updated on: March 30,2024

First 'gene silencing' drug for Alzheimer's disease shows promise

by University College LondonEffect of MAPTRxon CSF concentrations of p-tau protein and tau/Aβ42. a, The mean percentage change from baseline in p-tau over time according to dose group. b, T

Updated on:March 30,2024

Activity is important for your brain and for the prevention of Alzheimer's, suggests neurovascular study

by University of Copenhagen"By staying active, we are able to maintain a healthy vascular system so that the blood vessels stay flexible and retain the ability to drive forward the cerebrosp

Updated on: March 02,2024

Activity is important for your brain and for the prevention of Alzheimer's, suggests neurovascular study

by University of Copenhagen"By staying active, we are able to maintain a healthy vascular system so that the blood vessels stay flexible and retain the ability to drive forward the cerebrosp

Updated on:March 02,2024

Successful Phase 2 clinical trial for neflamapimod in mild-to-moderate Lewy body dementia

by University of North Carolina at Chapel Hill School of MedicineCredit: CC0 Public DomainEIP Pharma announced on October 6 that a phase 2 study in patients with mild-to-moderate Lewy body dement

Updated on: April 01,2024

Successful Phase 2 clinical trial for neflamapimod in mild-to-moderate Lewy body dementia

by University of North Carolina at Chapel Hill School of MedicineCredit: CC0 Public DomainEIP Pharma announced on October 6 that a phase 2 study in patients with mild-to-moderate Lewy body dement

Updated on:April 01,2024

Alzheimer's in one sibling raises risk of shortened lifespan in others

by Leigh Hopper,University of Southern CaliforniaCredit: CC0 Public DomainAn Alzheimer's diagnosis in a sibling raises the risk of a shortened lifespan in other family members—even those wit

Updated on: February 24,2024

Alzheimer's in one sibling raises risk of shortened lifespan in others

by Leigh Hopper,University of Southern CaliforniaCredit: CC0 Public DomainAn Alzheimer's diagnosis in a sibling raises the risk of a shortened lifespan in other family members—even those wit

Updated on:February 24,2024

Protein misfolding as a risk marker for Alzheimer's disease

by German Cancer Research CenterCredit: CC0 Public DomainIn symptom-free individuals, the detection of misfolded amyloid-β protein in the blood indicates a considerably higher risk of Alzheimer&#

Updated on: May 20,2024

Protein misfolding as a risk marker for Alzheimer's disease

by German Cancer Research CenterCredit: CC0 Public DomainIn symptom-free individuals, the detection of misfolded amyloid-β protein in the blood indicates a considerably higher risk of Alzheimer&#

Updated on:May 20,2024

Risk factors for faster aging in the brain revealed in new study

by University of OxfordTo the left of the figure, the red-yellow color denotes the regions that degenerate earlier than the rest of the brain, and are vulnerable to Alzheimer's disease. These

Updated on: March 30,2024

Risk factors for faster aging in the brain revealed in new study

by University of OxfordTo the left of the figure, the red-yellow color denotes the regions that degenerate earlier than the rest of the brain, and are vulnerable to Alzheimer's disease. These

Updated on:March 30,2024